SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-023409
Filing Date
2023-08-14
Accepted
2023-08-14 07:45:54
Documents
90
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20230630_10q.htm   iXBRL 10-Q 1917151
2 EXHIBIT 31.1 ex_528470.htm EX-31.1 12747
3 EXHIBIT 31.2 ex_528471.htm EX-31.2 12512
4 EXHIBIT 32.1 ex_528472.htm EX-32.1 6194
5 EXHIBIT 32.2 ex_528473.htm EX-32.2 6227
11 img.jpg GRAPHIC 83423
  Complete submission text file 0001437749-23-023409.txt   10408577

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20230630.xsd EX-101.SCH 97416
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20230630_cal.xml EX-101.CAL 63433
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20230630_def.xml EX-101.DEF 590005
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20230630_lab.xml EX-101.LAB 561267
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20230630_pre.xml EX-101.PRE 632964
84 EXTRACTED XBRL INSTANCE DOCUMENT clnn20230630_10q_htm.xml XML 1859495
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 231166325
SIC: 2834 Pharmaceutical Preparations